Oncolytic virotherapy as a personalized cancer vaccine
/in International Publications, Newcastle Disease Virus /von 2008-08-01 / Int. J. Cancer 2008 Aug;123(3):493-9Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
/in International Publications, Newcastle Disease Virus, NSCLC /von 2008-06-06 / Cancer Gene Ther. 2008 Dec;15(12):795-807Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-06-05 / Virus Res. 2008 Sep;136(1-2):75-80Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
/in Colorectal Cancer, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-9An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-04-01 / Int. J. Oncol. 2008 Apr;32(4):777-89Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles
/in International Publications, Newcastle Disease Virus /von 2008-03-04 / J. Neuroimmunol. 2008 Mar;195(1-2):21-7Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses
/in International Publications, Newcastle Disease Virus /von 2008-02-15 / Biochim. Biophys. Acta 2008 Apr;1785(2):217-31Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-02-13 / Cancer Immunol. Immunother. 2008 Sep;57(9):1421-7Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes
/in International Publications, Newcastle Disease Virus /von 2008-01-17 / Gene Ther. 2008 Mar;15(5):371-83
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de